QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
NASDAQ:CGEN

Compugen News Headlines

$6.12
-0.05 (-0.81 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.98
$6.24
50-Day Range
$5.80
$7.09
52-Week Range
$5.76
$15.16
Volume
741,403 shs
Average Volume
1.04 million shs
Market Capitalization
$418.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.32

Media Mentions By Week



Compugen Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CGEN
News Sentiment

0.26

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CGEN Articles
This Week

3

2

CGEN Articles
Average Week

Get Compugen News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter.

Compugen (NASDAQ:CGEN) News Headlines Today

SourceHeadline
MarketBeat logo-$0.12 EPS Expected for Compugen Ltd. (NASDAQ:CGEN) This Quarter
americanbankingnews.com - October 27 at 11:49 AM
finance.yahoo.com logoHere's Why We're Not Too Worried About Compugen's (NASDAQ:CGEN) Cash Burn Situation
finance.yahoo.com - October 26 at 9:02 AM
finance.yahoo.com logoCompugen to Release Third Quarter 2021 Results on Friday, November 12, 2021
finance.yahoo.com - October 26 at 9:02 AM
finance.yahoo.com logo/C O R R E C T I O N -- AION Labs/ - Yahoo Finance
finance.yahoo.com - October 13 at 3:41 PM
MarketBeat logoCompugen Target of Unusually High Options Trading (NASDAQ:CGEN)
americanbankingnews.com - October 13 at 11:37 AM
nasdaq.com logoShould You Buy Bel Fuse Inc. (NASDAQ:BELF.A) For Its Upcoming Dividend? - Nasdaq
nasdaq.com - October 9 at 10:52 PM
nasdaq.com logoReturns Are Gaining Momentum At Conformis (NASDAQ:CFMS) - Nasdaq
nasdaq.com - October 9 at 5:51 PM
nasdaq.com logoCompanies Like Compugen (NASDAQ:CGEN) Are In A Position To Invest In Growth - Nasdaq
nasdaq.com - October 9 at 12:48 PM
MarketBeat logoZacks: Brokerages Anticipate Compugen Ltd. (NASDAQ:CGEN) Will Announce Earnings of -$0.12 Per Share
americanbankingnews.com - October 8 at 1:16 PM
streetinsider.com logoCompugen (CGEN) Announces $6M Milestone Payment from AstraZeneca - StreetInsider.com
streetinsider.com - October 4 at 8:38 AM
finance.yahoo.com logoCompugen To Present Clinical Data from anti-TIGIT COM902 Monotherapy and Triple Combination Dose Escalation Studies at SITC 2021
finance.yahoo.com - October 1 at 12:07 PM
cnbc.com logoWhat to watch today: Dow set to drop about 700 points in global market sell-off - CNBC
cnbc.com - September 20 at 9:01 AM
cnbc.com logoStocks making the biggest moves premarket: Pfizer, Occidental Petroleum, Bank of America and more - CNBC
cnbc.com - September 20 at 9:01 AM
businesswire.com logoInsights on the Computational Biology Global Market to 2026 - Rising R&D for Drug Discovery Presents Opportunities - ResearchAndMarkets.com - Business Wire
businesswire.com - September 16 at 10:51 PM
finance.yahoo.com logoCompugen to Present at the Cantor Global Healthcare Conference
finance.yahoo.com - September 14 at 9:54 AM
finance.yahoo.com logoHere's Why We Think Compugen Ltd.'s (NASDAQ:CGEN) CEO Compensation Looks Fair for the time being
finance.yahoo.com - August 27 at 8:20 AM
finance.yahoo.com logoCompugen to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
finance.yahoo.com - August 26 at 8:31 AM
finance.yahoo.com logoCompugen Announces Bispecific Antibody Derived from COM902 to Enter Clinical Development
finance.yahoo.com - August 19 at 9:48 AM
nasdaq.com logoThose who invested in Compugen (NASDAQ:CGEN) three years ago are up 121%
nasdaq.com - August 10 at 5:06 PM
finance.yahoo.com logoCompugen Reports Second Quarter 2021 Results - Yahoo Finance
finance.yahoo.com - July 30 at 7:31 AM
streetinsider.com logoForm 6-K COMPUGEN LTD For: Jul 29 - StreetInsider.com
streetinsider.com - July 29 at 3:35 PM
fool.com logoWhy Compugen Stock Is Rising Again Today - Motley Fool
fool.com - July 29 at 3:35 PM
nasdaq.com logoAvery Dennison Q2 21 Earnings Conference Call At 1:00 PM ET - Nasdaq
nasdaq.com - July 29 at 5:34 AM
fool.com logoCompugen Ltd (CGEN) Q2 2021 Earnings Call Transcript - Motley Fool
fool.com - July 28 at 10:36 PM
finance.yahoo.com logoCompugen Ltd (CGEN) Q2 2021 Earnings Call Transcript
finance.yahoo.com - July 28 at 10:35 PM
nasdaq.com logoIs It Time to Sell AMC Stock and Buy IMAX? - Nasdaq
nasdaq.com - July 28 at 12:34 PM
finance.yahoo.com logoCompugen Reports Second Quarter 2021 Results
finance.yahoo.com - July 28 at 7:33 AM
finance.yahoo.com logoCompugen Doses First Patient in Phase 1/2 Triple Combination Cohort Expansion of COM701 with Opdivo® and Bristol Myers Squibb's Anti-TIGIT Antibody, BMS-986207 - Yahoo Finance
finance.yahoo.com - July 19 at 2:53 PM
finance.yahoo.com logoCompugen Doses First Patient in Phase 1/2 Triple Combination Cohort Expansion of COM701 with Opdivo® and Bristol Myers Squibb's Anti-TIGIT Antibody, BMS-986207
finance.yahoo.com - July 19 at 9:52 AM
finance.yahoo.com logoCompugen Doses First Patient in Phase 1 Combination Study of COM902 and COM701 in Patients with Advanced Malignancies
finance.yahoo.com - July 15 at 10:18 AM
finance.yahoo.com logoCompugen to Release Second Quarter 2021 Results on Wednesday, July 28, 2021
finance.yahoo.com - July 14 at 4:42 PM
finance.yahoo.com logoCompugen to Release Second Quarter 2021 Results on Wednesday, July 28, 2021 - Yahoo Finance
finance.yahoo.com - July 14 at 11:41 AM
finance.yahoo.com logoDo Institutions Own Compugen Ltd. (NASDAQ:CGEN) Shares? - Yahoo Finance
finance.yahoo.com - July 9 at 9:10 AM
finance.yahoo.com logoDo Institutions Own Compugen Ltd. (NASDAQ:CGEN) Shares?
finance.yahoo.com - July 9 at 9:10 AM
seekingalpha.com logoDosing underway in Compugen's COM701/Opdivo Phase 1b cohort expansion study - Seeking Alpha
seekingalpha.com - June 30 at 2:12 PM
finance.yahoo.com logoCompugen Doses First Patient in COM701/Opdivo® (nivolumab) Phase 1b Cohort Expansion Study
finance.yahoo.com - June 30 at 9:11 AM
finance.yahoo.com logoCompugen Presents Research Supporting PVRIG as a Novel and Differentiated Checkpoint in the DNAM-1 Axis
finance.yahoo.com - June 29 at 9:20 AM
seekingalpha.com logoKaleido Biosciences, Pieris Pharmaceuticals leads healthcare gainers; Portage Biotech, Rite Aid among major losers - Seeking Alpha
seekingalpha.com - June 24 at 3:06 PM
seekingalpha.com logoCompugen gains on takeover speculation after iTeos Therapeutics deal - Seeking Alpha
seekingalpha.com - June 14 at 12:30 PM
nasdaq.com logoAre Institutions Heavily Invested In Compugen Ltd.'s (NASDAQ:CGEN) Shares? - Nasdaq
nasdaq.com - June 11 at 10:27 PM
finance.yahoo.com logoCompugen Announces Updated Data from Phase 1 Study of COM701, First- in-Class Anti-PVRIG, at the ASCO 2021 Annual Meeting - Yahoo Finance
finance.yahoo.com - June 8 at 7:47 PM
finance.yahoo.com logoCompugen's COM701 Shows Treatment Durability Beyond One Year in Solid Tumor Patients
finance.yahoo.com - June 8 at 2:46 PM
finance.yahoo.com logoCompugen Announces Updated Data from Phase 1 Study of COM701, First- in-Class Anti-PVRIG, at the ASCO 2021 Annual Meeting
finance.yahoo.com - June 8 at 9:46 AM
finance.yahoo.com logoCompugen Management to Discuss COM701 Data Presented at ASCO at Event Hosted by Truist Securities - Yahoo Finance
finance.yahoo.com - June 1 at 8:50 AM
finance.yahoo.com logoCompugen Management to Discuss COM701 Data Presented at ASCO at Event Hosted by Truist Securities
finance.yahoo.com - June 1 at 8:50 AM
bloomberg.com logoCathie Wood Is Trimming Her Biggest Stakes as Ark Funds Stumble - Bloomberg
bloomberg.com - May 22 at 2:31 PM
finance.yahoo.com logoCathie Wood Is Trimming Her Biggest Stakes as Ark Funds Stumble
finance.yahoo.com - May 22 at 2:31 PM
nasdaq.com logoWhy Compugen Stock Is Jumping Today - Nasdaq
nasdaq.com - May 15 at 7:10 PM
fool.com logoWhy Compugen Stock Is Jumping Today - Motley Fool
fool.com - May 14 at 6:38 PM
fool.com logoCompugen Ltd. (CGEN) Q1 2021 Earnings Call Transcript - Motley Fool
fool.com - May 14 at 8:37 AM
Get Compugen News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.